Total income £140.4m in 2024/25 — record third consecutive year; £61.6m from direct gifts; £29.9m from legacies; 90,000+ new committed givers joined in year
Key Metric 1
55 research grants funded in 2024-25 (up significantly — amount invested trebling in recent years); four new partnerships including Cancer Research UK for children's and young people's cancer data challenges
Key Metric 2
£295.5m committed by board to Children's Cancer Centre project (December 2024) — plus £34.5m already committed — total £330m; first targeted treatment for brain tumours in children approved for NHS patients (from research by GOSH Charity Professor Darren Hargrave)
Key Metric 3
First-ever targeted treatment for children's brain tumours approved for NHS following decades of GOSH Charity-funded research — alternative to chemotherapy now available; Children's Cancer Centre main works contract milestones reached; deconstruction work began February 2025